App-Quantinova.ai

Improved Thrombolysis Rates and Quality of Care for Stroke Patients Through a Provincial Emergency Department Quality Improvement Initiative

Robert Stenstrom - American Heart Association (AHA) , 2013

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Stroke

Aspirin

Dynamic Characterization of CT Angiographic Spot Sign

Mohammed Alhazzaa - American Heart Association (AHA) , 2014

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Intracerebral hemorrhage

N/A

Magnitude of Acute Blood Pressure Decrease Does Not Predict the Presence of Diffusion-Restricted Lesions in Patients With Intracerebral Hemorrhage

Victor Choi - American Heart Association (AHA) , 2014

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Intracerebral hemorrhage

N/A

Using Scarce Stroke Care Resources for the Greatest Impact: Examining Ontarios Stroke Report Card 2011/12

North - American Heart Association (AHA) , 2014

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Stroke

N/A

Developmental Evaluation Enhances Utility of the Toronto Stroke Networks Virtual Community of Practice

Michelle Donald - American Heart Association (AHA) , 2014

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Stroke

N/A

Health Care Professional- Perspectives on Implementing Family Caregiver Education and Support Programs into the Ontario Stroke System

Susan Jaglal - American Heart Association (AHA) , 2014

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Stroke

N/A

Developing Excellence in Stroke Care Through Knowledge Building and Interprofessional Collaborative Processes

Michelle Donald - American Heart Association (AHA) , 2014

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Stroke

N/A

Therapeutically Targeting TNF?-S1P Signaling Restores Microvascular Reactivity after Experimental Subarachnoid Hemorrhage

Div of Neurosurgery - American Heart Association (AHA) , 2013

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Subarachnoid hemorrhage

Phenylephrine

Use of Strategies to Improve Door-to-Needle Times with Tissue Plasminogen Activator in Acute Ischemic Stroke by US Hospitals: Findings from the Target: Stroke Survey

Eric E Smith - American Heart Association (AHA) , 2013

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Ischemic stroke

N/A

Acute Blood Pressure Reduction in Intracerebral Hemorrhage Patients Does Not Increase Hypoperfused Tissue Volume: a CT Perfusion Threshold Study

Rebecca McCourt - American Heart Association (AHA) , 2013

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Intracerebral hemorrhage

N/A

Cardio-Respiratory Arrest in Stroke (CAIS Study): Predisposing Factors, Clinical Features, Outcomes, and Process Measures

Alejandro Rabinstein - American Heart Association (AHA) , 2014

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Congestive heart failure

N/A

Evaluating Low Rates of Oral Anticoagulant Prescribing for Secondary Stroke Prevention in Ontario

Shudong Li - American Heart Association (AHA) , 2014

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Arrhythmia

Warfarin

Management of TIA Patients Referred to Ontario Secondary Stroke Prevention Clinics From the Emergency Department

Ferhana Khan - American Heart Association (AHA) , 2014

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Transient Ischemic Attack

N/A

A Functional Recovery Analysis of Inpatient Rehabilitation for Mild Stroke Patients

Patrice Lindsay - American Heart Association (AHA) , 2013

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Stroke

N/A

Anticoagulation Remains Underutilized in the Management of Atrial Fibrillation: Results From the Edmonton Registry of Atrial Fibrillation and StrokE (ERASE) Study

Ashfaq Shuaib - American Heart Association (AHA) , 2014

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Non-valvular atrial fibrillation

Warfarin

Variation and Trends in the Documentation of National Institutes of Health Stroke Scale (NIHSS) Among GWTG-Stroke Hospitals

Eric E Smith - American Heart Association (AHA) , 2014

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Ischemic stroke

N/A

Evaluating Gaps in the Continuum of Stroke Care

Jenny P Tsai - American Heart Association (AHA) , 2014

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Ischemic stroke

N/A

Benign Natural History of Occlusion in Asymptomatic Carotid Stenosis

J David Spence - American Heart Association (AHA) , 2014

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Carotid artery stenosis

N/A

The Toronto Stroke Networks Virtual Community of Practice: Collaborative Change Leadership to Create Enhanced Purpose for Best Practice Implementation

Joanne Fortin - American Heart Association (AHA) , 2013

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Stroke

N/A

Baseline Perihematomal Edema is Greater in the Presence of a CTA Spot Sign but Does Not Predict Hematoma Expansion Independent of ICH Volume

David Rodriguez-Luna - American Heart Association (AHA) , 2013

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Intracerebral hemorrhage

rFVIIa

Filters

28841 Abstracts